Verkazia 1 mg/ml Eye Drops Emulsion 0.3 ml × 30's

Verkazia® is the first and only FDA-approved ophthalmic treatment for vernal keratoconjunctivitis (VKC), a rare and severe allergic eye disease that mainly affects children but can also occur in adults. It contains cyclosporine 0.1% as an immunomodulator to control eye inflammation, reduce itching, and protect the cornea. Unlike steroids, Verkazia® is steroid-free, making it a long-term option for managing VKC without the risks associated with corticosteroids.